These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34464081)

  • 1. Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy.
    Jiang L; Gu Y; Du Y; Tang X; Wu X; Liu J
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):42411-42428. PubMed ID: 34464081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
    Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
    J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. αvβ3 integrin-specific exosomes engineered with cyclopeptide for targeted delivery of triptolide against malignant melanoma.
    Gu Y; Du Y; Jiang L; Tang X; Li A; Zhao Y; Lang Y; Liu X; Liu J
    J Nanobiotechnology; 2022 Aug; 20(1):384. PubMed ID: 35999612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
    Brincks EL; Kucaba TA; James BR; Murphy KA; Schwertfeger KL; Sangwan V; Banerjee S; Saluja AK; Griffith TS
    FEBS J; 2015 Dec; 282(24):4747-4765. PubMed ID: 26426449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Triptolide-Loaded Exosomes on the Proliferation and Apoptosis of Human Ovarian Cancer SKOV3 Cells.
    Liu H; Shen M; Zhao D; Ru D; Duan Y; Ding C; Li H
    Biomed Res Int; 2019; 2019():2595801. PubMed ID: 31240207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.
    Dai H; Jiang Y; Luo Y; Bie P; Chen Z
    Phytomedicine; 2019 Sep; 62():152953. PubMed ID: 31128486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer.
    Wang Y; Liu T; Li H
    J Biomater Sci Polym Ed; 2016; 27(7):545-56. PubMed ID: 26786618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment.
    Wu B; Lu ST; Zhang LJ; Zhuo RX; Xu HB; Huang SW
    Int J Nanomedicine; 2017; 12():1853-1862. PubMed ID: 28331310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy.
    Zheng Y; Kong F; Liu S; Liu X; Pei D; Miao X
    Drug Deliv; 2021 Dec; 28(1):2033-2043. PubMed ID: 34569906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
    Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M
    Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
    Liu Y; Xiao E; Yuan L; Li G
    DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.
    Hung FM; Chen YL; Huang AC; Hsiao YP; Yang JS; Chung MT; Chueh FS; Lu HF; Chung JG
    Oncol Rep; 2013 Mar; 29(3):1053-60. PubMed ID: 23314229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
    Yang M; Gu Y; Yang D; Tang X; Liu J
    J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model.
    Shamili FH; Bayegi HR; Salmasi Z; Sadri K; Mahmoudi M; Kalantari M; Ramezani M; Abnous K
    Int J Pharm; 2018 Oct; 549(1-2):218-229. PubMed ID: 30075248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ.
    Cai J; Yi M; Tan Y; Li X; Li G; Zeng Z; Xiong W; Xiang B
    J Exp Clin Cancer Res; 2021 Jun; 40(1):190. PubMed ID: 34108030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
    Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
    J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.
    Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC
    Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecularly Engineering Triptolide with Aptamers for High Specificity and Cytotoxicity for Triple-Negative Breast Cancer.
    He J; Peng T; Peng Y; Ai L; Deng Z; Wang XQ; Tan W
    J Am Chem Soc; 2020 Feb; 142(6):2699-2703. PubMed ID: 31910009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LLDT-288, a novel triptolide analogue exhibits potent antitumor activity in vitro and in vivo.
    Xu H; Fan X; Zhang G; Liu X; Li Z; Li Y; Jiang B
    Biomed Pharmacother; 2017 Sep; 93():1004-1009. PubMed ID: 28724258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining triptolide with ABT-199 is effective against acute myeloid leukemia through reciprocal regulation of Bcl-2 family proteins and activation of the intrinsic apoptotic pathway.
    Shi YF; Liu L; He LL; Ye J; Lin ZJ; Yuan DL; Deng MM; Fang ZH; Carter BZ; Xu B
    Cell Death Dis; 2020 Jul; 11(7):555. PubMed ID: 32699295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.